chief executive officer Ronny Skuggedal

Mr. Skuggedal joined PCI Biotech in October 2013 as CFO with responsibility for finance, accounting and investor relations, and with a key role in business development. Ronny was appointed Interim CEO effective 1st June 2022, and promoted to CEO effective 1st September 2022. He holds a Master of Science in Economics and Business Administration from the Norwegian School of Economics (NHH) and a Master in Professional Accountancy from BI Norwegian Business School. Before joining PCI Biotech, he was a Director at PwC within Assurance and he has twelve years of experience from auditing and advisory services.